CDADC1 and Decreased total leukocyte count: Gemcitabine caused pronounced thrombocytopenia and leukopenia, with highly reduced myeloid and lymphoid cells within the bone marrow, in Cdadc1−/− mice (Fig. 4 H and I and SI Appendix, Fig. S7 A and B).